BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1368937)

  • 1. Vaccinia and other poxvirus expression vectors.
    Moss B
    Curr Opin Biotechnol; 1992 Oct; 3(5):518-22. PubMed ID: 1368937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poxvirus vectors: cytoplasmic expression of transferred genes.
    Moss B
    Curr Opin Genet Dev; 1993 Feb; 3(1):86-90. PubMed ID: 8453278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poxviruses as vaccine vectors.
    Pastoret PP; Vanderplasschen A
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
    Paoletti E; Taylor J; Meignier B; Meric C; Tartaglia J
    Dev Biol Stand; 1995; 84():159-63. PubMed ID: 7796949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflections on the early development of poxvirus vectors.
    Moss B
    Vaccine; 2013 Sep; 31(39):4220-2. PubMed ID: 23583893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly attenuated poxvirus vectors.
    Tartaglia J; Cox WI; Taylor J; Perkus M; Riviere M; Meignier B; Paoletti E
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1445-7. PubMed ID: 1466978
    [No Abstract]   [Full Text] [Related]  

  • 7. Roles of vaccinia virus in the development of new vaccines.
    Moss B; Fuerst TR; Flexner C; Hugin A
    Vaccine; 1988 Apr; 6(2):161-3. PubMed ID: 3291453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
    Moss B
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11341-8. PubMed ID: 8876137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of recombinant fowlpox viruses as vectors for poultry vaccines.
    Boyle DB; Coupar BE
    Virus Res; 1988 Jun; 10(4):343-56. PubMed ID: 2842977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabies vaccine. Developments employing molecular biology methods.
    Paolazzi CC; Pérez O; De Filippo J
    Mol Biotechnol; 1999 Apr; 11(2):137-47. PubMed ID: 10464768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines.
    Xing Z; Santosuosso M; McCormick S; Yang TC; Millar J; Hitt M; Wan Y; Bramson J; Vordermeier HM
    Curr Gene Ther; 2005 Oct; 5(5):485-92. PubMed ID: 16250889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins.
    Wyatt LS; Xiao W; Americo JL; Earl PL; Moss B
    mBio; 2017 Jun; 8(3):. PubMed ID: 28588133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development.
    Moss B
    Dev Biol Stand; 1994; 82():55-63. PubMed ID: 7958483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The vaccinia virus as a vector for genetically engineered vaccines and the study of viral protein functions].
    Vopr Virusol; 1986; 31(4):509-12. PubMed ID: 3464128
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
    Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tools for the targeted genetic modification of poxvirus genomes.
    Matía A; Lorenzo MM; Blasco R
    Curr Opin Virol; 2020 Oct; 44():183-190. PubMed ID: 33242829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poxvirus-based vectors as vaccine candidates.
    Tartaglia J; Pincus S; Paoletti E
    Crit Rev Immunol; 1990; 10(1):13-30. PubMed ID: 2407263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poxvirus recombinant vaccines.
    Paoletti E
    Ann N Y Acad Sci; 1990; 590():309-25. PubMed ID: 2198832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The uses of poxviruses as vectors.
    Vanderplasschen A; Pastoret PP
    Curr Gene Ther; 2003 Dec; 3(6):583-95. PubMed ID: 14683453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.